GG 1978 SICAF SIF S.A.
SEC CIK 1814891 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RPRX | Royalty Pharma plc | 10% | 21.43M | — | $25.70M | 3 | 2022-08-25 | 2022-09-20 |
Most active insiders at RPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coyne Terrance P. | EVP, CFO | — | $38.96M |
| 2 | Hite Christopher | EVP, Vice COB | — | $27.36M |
| 3 | Lloyd George W. | EVP, CLO, Investments | — | $13.81M |
| 4 | Urist Marshall | EVP, Research, Investments | — | $12.07M |
| 5 | Norden Gregory | Dir | — | $161.4K |
| 6 | Engelbert Catherine M. | Dir | — | — |
| 7 | Ho Carole | Dir | — | — |
| 8 | Coric Vlad | Dir | — | — |
| 9 | Bassler Bonnie L | Dir | — | — |
| 10 | Legorreta Pablo G. | CEO, COB, Dir | — | — |
GG 1978 SICAF SIF S.A. made no open-market trades at RPRX in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-09-22 | 2022-09-20 | RPRX | Royalty Pharma plc | GG 1978 SICAF SIF S.A. | 10% | S - Sale | $41.02 | -267.8K | 21.43M | -1% | -$10.99M |
| MI | 2022-09-16 | 2022-09-14+ | RPRX | Royalty Pharma plc | GG 1978 SICAF SIF S.A. | 10% | S - Sale | $42.38 | -345.0K | 22.08M | -2% | -$14.62M |
| I | 2022-08-29 | 2022-08-25 | RPRX | Royalty Pharma plc | GG 1978 SICAF SIF S.A. | 10% | S - Sale | $44.00 | -1,994 | 22.92M | -0.0% | -$87.7K |
Purchase Sale Sale after option exercise All abbreviations